By Whitney Smith, Scientific, Sales and Product Expertise in Life Science Software and Services There's a particular kind of frustration that shows up on deal teams and in legal departments at pharma and biotech companies, usually a few weeks into due diligence, a licensing evaluation, or a patent dispute. Someone on the legal or M&A side needs a clear, defensible picture of a research program: what was tested, when, by whom, under what conditions, with what results. It sound

Data, AI, and the Next Generation of Clinical Diagnostics for Rare Immune Disorders Nazanin Fathi, Ph.D. | Immunology Visioneer, 20/15 Visioneers | July 2026 Summary: Among the most diagnostically complex conditions in clinical medicine are diseases in which the immune system fails—not because of infection or cancer, but because of underlying genetic defects that impair immune development, signalling, or function. Inborn errors of immunity (IEIs), a group of more than

An accessible industry overview of the science, clinical workflow, commercialization challenges, and data foundation behind targeted radiopharmaceuticals By Charlie Fetsko, 20/15 Visioneer Intern Overview Radioligand therapy (RLT) is a rapidly advancing form of precision cancer treatment that uses a tumor-seeking molecule to carry radiation directly to cancer cells. Unlike external-beam radiation therapy, which directs radiation into the body from an external source, RLT trav

By Kelly Cycon, PhD | 20/15 Visioneers If you’ve ever watched a term sheet slow down over a question that had nothing to do with your science, this is for you. Every founder braces for the funding valley of death, and an entire ecosystem of grants, accelerators, and tech‑transfer programs exists to pull them across it. Almost no one warns you about the second valley: the operational gap that gets exposed at diligence, IND, and partnership; where fundable science stalls, not b

By 20/15 Visioneers May 2026 Executive Summary Clinical development is at an inflection point. Since the adoption of Electronic Data Capture, the industry has focused primarily on execution efficiency, optimizing CROs, site networks, and operational workflows. That paradigm is giving way to something more fundamental: designing better trials before they begin and ultimately getting much-needed medicines and therapies to patients faster. The convergence of Artificial Intell

several master data configurations for new LIMS deployments, a.k.a. paper-to- by Steven Bates, Ph.D. I’ve led several master data configurations for new LIMS deployments, a.k.a. paper-to- LIMS transitions, for which there’s a certain art. However, it’s just as common for an organization to already have an existing informatics system that they want to transition from to a new system. This has its own particular challenges, but many of the lessons from configuring master data f

A collaborative perspective from Automata and 20/15 Visioneers January 2026 Abstract Laboratory automation stands at a critical inflection point. While technology has matured significantly, 50-75% of automation initiatives fail, not from technical limitations, but from cultural and organizational challenges. Unfortunately, this failure rate is common in Life Science initiatives. This white paper presents a practical framework for laboratory transformation that addresses both

By John F. Conway Chief Visioneer Officer What Disney Imagineers Can Teach Drug and Therapy Discovery Operations About Data and Reproducibility In the early days of Walt Disney’s Imagineering team, the magic was real – but the record-keeping was not. According to Imagineering lore, almost nothing was written down in those pioneering years.[1] Ride concepts and design tweaks were tacit knowledge that lived in engineers’ heads or in ad-hoc conversations. Reproducibility was es

“The Long Evolution of Scientific Work, and the Disruptive Arrival of AI" by Steven Bates, Ph.D. The latest generation of AI tools has already begun to be transformative to scientific informatics, and this may be only the beginning stages of an even more profound transformation of the nature of scientific work, and of the products of scientists’ labor. As those changes arrive, people are having to grapple with the adjustments in thinking needed to take the fullest advantag

By Steven Bates, Ph.D. When I worked as a bench scientist, one of the truisms I learned about proteomics (and molecular biology in general) was that they’re “as much an art as a science.” In my experience, the same is true in many respects for Scientific Data Management. I’ve lately taken to calling myself a Data Sculptor, which is only half tongue-in-cheek. The metaphor already gets some usage in software development with wireframes. Like a physical wireframe, an informati

By Alexander Goldberg, Ph.D. Visiting Senior Materials Science Visioneer A new angle on nuclear waste management through carbon nanomaterials and molecular modeling. As the global nuclear energy landscape evolves, decommissioning of nuclear reactors has emerged as a critical task—not only from a technical standpoint but also from environmental and policy perspectives. One of the most persistent challenges is the long-term storage of radioactive isotopes, especially cesium-13

By the Team at 20/15 Visioneers Problem Statement: “With a Next-Generation LIMS like Semaphores Labbit™, the high amount of money and...

June 2024 By 20/15 Visioneers Team Background Today’s biopharma collaboration or “externalization” cannot be efficiently achieved without...

Process Optimized Drug Discovery Efficiency Gains with eMolecules’ FAIR and Integrated Unity Platform ________________ By 20/15...

We eliminate the daily friction that slows down your scientists, empowering them to focus on breakthrough science; Scientists will be empowered to configure the system, so they can move fast; Enforce consistency and reduce risk with automated business rules, ensuring seamless alignment with partners and CROs Let Your Scientists Focus on What Matters Most — Science Contact us to learn more: info@scigilian.com Efficient lab operations revolve around managing complexity, reliabi

LLM/ML-Enabled Real-Time Protocol Adjustment Executive Summary This case study examines the transformation of PCR optimization workflows...

Authored by 20/15 Visioneers Background ZONTAL ( zontal.io ) is a scientific software company pioneering FAIR (Findable, Accessible,...

Now You Can Scale to 1TB/hour and 5,000 Instruments and Beyond, Which Equates to NASDAQ and the Dow Jones Combined! Wolfgang Colsman, CEO...

Laboratory automation in life sciences has traditionally focused on hardware integration and physical workflows. However, the true value...

Rick Hart, Senior Scientific Informatics Visioneer, is a veteran scientific informatics expert with a long career in consulting and...